Our clinical studies show increase in treatment adherence and patient engagement fostering lasting behavioral changes. Actual improvement of patients’ quality of life is what moves us forward.
MEDTEP HEMOPHILIA
The use of Medtep Hemophilia helps patients to improve adherence to prophylactic treatment. These results open new possibilities for the therapeutic and preventive treatments of these patients, especially the young.
Publications
WFH Congress 2016
Moderated Poster presented on July 27, 2016 in Orlando, Fl for the WFH Congress 2016.
The use of Medtep’s online platform helps PWH improve adherence to prophylactic treatment
Clinicaltrials.gov
ClinicalTrials.gov is a service of the U.S. National Institutes of Health. It is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.
Effectiveness of the Medtep Platform in Prophylactic Treatment in Hemophilia
VERITAS-Pro Scale improvement
After one year of Medtep Hemophilia use, patients in the study reach on average a total VERITAS-Pro Scale of 34, which accounts for a 90% of treatment adherence2,3.
Adherence to prophylactic treatment measured by VERITAS-Pro scale (Veritas-PRO total scores range from 120 -least adherent- to 24 -most adherent-).
Treatment compliance
Treatment compliance improved by 47% over usual treatment1.
Treatment compliance in active patients using Medtep
USUAL TREATMENT – 50%
1ST MONTH RESULTS – 64%
6TH MONTH RESULTS – 94%
ONE YEAR RESULTS – 97%
Cost-effective solution
As adherence to prophylaxis treatment has proven to reduce bleeding occurrences4, Medtep Hemophilia can reduce costs5 per avoided bleeding episode in a patient with severe hemophilia without inhibitors.
Sources
1 Remor E. Predictors of treatment difficulties and satisfaction with haemophilia therapy in adult patients. 2011;17:e901 – e905 [Haemophilia]
2 Lock J, Raat H, Duncan N, et al. Adherence to treatment in a Western European paediatric population with haemophilia: reliability and validity of the VERITAS-Pro scale. 2014; 20: 616–623 [Haemophilia]
3 Duncan N, Kronenberger W, Roberson C, et al. VERITAS – Pro: a new measure of adherence to prophylactic regimens in hemophilia. 2010; 16: 247–255 [Haemophilia]
4 Collins P W, Blanchette V S, Fischer K, et al. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. 2008;7: 413–420. [Journal of Thrombosis and Haemostasis]
5 Lippert B, Berger K, Berntorp E, et al. Cost effectiveness of haemophilia treatment: a cross-national assessment. 2005;16(7):477–485. [PubMed]
MEDTEP ASTHMA
Improvements in asthma control were achieved in patients who received Medtep Asthma support for 6 months, decreasing assistance in emergency services and, as a result, requiring less treatment.
Publications
Journal of Pulmonary & Respiratory Medicine
Journal of Pulmonary & Respiratory Medicine is a peer reviewed medical journal that focus on a wide range of areas in this field including pulmonary, respiratory diseases related to respiratory system and treatment methods.
Application of Telemedicine for the Optimal Control of Asthma Patients
Wonca Europe
Wonca Europe is the academic and scientific society for general practitioners in Europe. It has 47 member organisations and represents more than 75.000 family physicians in Europe.
Wonca Europe Congress – Copenhagen 2016
Application of Telemedicine for the Optimal Control of Asthma Patients
Treatment compliance
The pharmacological compliance has been over 95% in active patients.
Base treatment improvement
Percentage of patients that have improved their level related to the base treatment in the first six months after using Medtep Asthma.
Patient engagement
Four out of five patients have entered data on a daily basis.
Cost-effective solution
Medtep Asthma contributes up to 25% annual cost reduction per patient to the National Health Service.1.
Sources
1 Martínez E, Serra J, De Diego A, et al. Economic Cost of Treating the Patient With Asthma in Spain: The AsmaCost Study. 2009; 45(10):481-486[Arch Bronconeumol]
MEDTEP DBT
Medtep DBT care plan is a further step in combining digital technology with the expertise of healthcare professionals in the mental health area. Medtep DBT can help get the maximum outcomes possible out of the DBT.
Publications
4th International Congress on Borderline Personality Disorder and Allied Disorders
Oral Communication presented on September 8, 2016, in Vienna (Austria) for the 4th International Congress on Borderline Personality Disorder and Allied Disorders.
Medtep DBT: A digital health app based on the dialectical behavior therapy by Dr. Marsha M. Linehan (Cognitive-behavioral treatment of borderline personality disorder and skills training manual for treating borderline personality disorder)
MEDTEP OBESITY
9.2% of the patients in the intervention group using Medtep’s digital platform obtained and maintained a more than 5% weight reduction
Obesity Management Analysis through different therapeutic techniques
Publications
Journal of Telemedicine and Telecare
This publication provides excellent coverage of developments in telemedicine and e-health with a focus on clinical trials of telemedicine applications.
Application of telemedicine in obesity management
Effective solution
Medtep Obesity was 6 times more effective to maintain at least 5% weight reduction at treatment completion.
Higher weight loss
The average weight loss using Medtep platform was 2.5 times higher than the control group under usual treatment.
Making a difference
Average weight loss using Medtep Platform reached up to 5.3Kg, increasing by 5 times the reported weight loss by other apps in a the market1
Sources
1 Flores Mateo G, Granado-Font E, Ferré-Grau C, Montaña-Carreras X. Mobile Phone Apps to Promote Weight Loss and Increase Physical Activity: A Systematic Review and Meta-Analysis. Bamidis P, ed. Journal of Medical Internet Research. 2015;17(11):e253. doi:10.2196/jmir.4836